We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
International Biotechnology Trust Plc | LSE:IBT | London | Ordinary Share | GB0004559349 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 712.00 | 702.00 | 708.00 | 4,382 | 08:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 12.06M | 6.81M | 0.1878 | 37.91 | 258.3M |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")
Latest Factsheet and Blog
IBT's factsheet for the month ended 31 October 2024 is now available directly via its web page. Please click here, then 'latest factsheet'.
Obesity has long been a significant global health challenge, particularly in the western world, due to the implications it can have for associated conditions such as heart disease, diabetes and certain cancers. Until recently, treatments focused on lifestyle changes and pharmacological interventions like appetite suppressants and fat absorption inhibitors. However, these early drugs often had limited efficacy and significant side effects, leading to a persistent demand for more effective solutions. Here, we explore the continued innovation taking place in the obesity medication space.
The blog can be read here:
https://www.schroders.com/en-gb/uk/individual/content/the-future-of-obesity/
To sign up for IBT updates by email, please click here.
ENDS
Enquiries:
Schroder Investment Management Limited
Kirsty Preston (PR)
Kerry Higgins (Company Secretary) |
020 7658 6000
020 7658 6000
|
|
|
Kaso Legg Communications (Financial PR)
Charles Gorman Henry Taylor Effie Aye Maung Hider |
|
|
|
1 Year International Biotechnol... Chart |
1 Month International Biotechnol... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions